GLP-2: what do we know? What are we going to discover?

Regul Pept. 2014 Nov:194-195:6-10. doi: 10.1016/j.regpep.2014.09.002. Epub 2014 Sep 16.

Abstract

Glucagon-like peptide 2 [GLP-2] is a 33-amino acid peptide released from the mucosal enteroendocrine L-cells of the intestine. The actions of GLP-2 are transduced by the GLP-2 receptor [GLP-2R], which is localized in the neurons of the enteric nervous system but not in the intestinal epithelium, indicating an indirect mechanism of action. GLP-2 is well known for its trophic role within the intestine and interest in GLP-2 is now reviving based on the approval of the GLP-2R agonist for treatment of short bowel syndrome [SBS]. Recently it also seems to be involved in glucose homeostasis. The aim of this review is to outline the importance of neuroendocrine peptides, specifically of GLP-2 in the enteric modulation of the gastrointestinal function and to focus on new works in order to present an innovative picture of GLP-2.

Keywords: GLP-2; GLP-2 receptor; The enteric nervous system; The gastrointestinal tract.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Enteric Nervous System / metabolism
  • Gastrointestinal Tract / metabolism
  • Glucagon-Like Peptide 2 / metabolism*
  • Humans
  • Inflammation
  • Signal Transduction

Substances

  • Glucagon-Like Peptide 2